STOCK TITAN

Labcorp to Announce First Quarter Financial Results on April 25, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Labcorp (LH) will release its financial results for Q1 2024 on April 25, 2024. A conference call and webcast will follow to discuss the results. The earnings press release will be available on Labcorp's Investor Relations website. Participants can register to receive dial-in numbers for the call. A replay will be accessible until April 11, 2025.
Positive
  • None.
Negative
  • None.

BURLINGTON, N.C., March 27, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the first quarter of 2024 before the market opens on Thursday, April 25, 2024. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

The call will be webcast live on the Labcorp Investor Relations website. Participants may also register for the call by clicking on this link, to receive the dial-in numbers and unique PIN to access the call. The webcast and dial-in are listen-only. It is recommended that participants join 10 minutes prior to the start, although participants may register and join at any time during the call.

A replay of the webcast will be available approximately two hours after the conclusion of the live event and will be available until April 11, 2025. To access the webcast recording, visit the Labcorp Investor Relations website.

About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's more than 67,000 employees serve clients in approximately 100 countries, provided support for 84% of the new drugs and therapeutic products approved in 2023 by the FDA and performed more than 600 million tests for patients around the world. Learn more about us at www.Labcorp.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-announce-first-quarter-financial-results-on-april-25-2024-302100943.html

SOURCE Laboratory Corporation of America Holdings

Labcorp will release its financial results for the first quarter of 2024 on Thursday, April 25, 2024.

The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.

Yes, the call will be webcast live on the Labcorp Investor Relations website. Participants can register to receive dial-in numbers for the call.

The replay of the webcast will be available until April 11, 2025. Participants can access the recording on the Labcorp Investor Relations website.
Laboratory Corp. Of America Holdings

NYSE:LH

LH Rankings

LH Latest News

LH Stock Data

Diagnostic Imaging Centers
Health Care and Social Assistance
Link
Health Services, Services to the Health Industry, Manufacturing, Dental Laboratories
US
Burlington

About LH

recognized for our innovation, quality, and customer convenience, labcorp delivers timely, accurate results for improved patient care. with scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, labcorp performs more than one million tests on approximately 400,000 samples each day. labcorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. labcorp operates a sophisticated laboratory network, with corporate headquarters in burlington, nc, and more than 34,000 employees worldwide. our more than 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. laboratory corporation of america holdings is listed on the new york stock exchange (nyse) under ticker symbol lh.